1 / 3

Global Anticoagulants Market

Global Anticoagulants Market size was valued at USD 27.9 billion in 2021 and is poised to grow from USD 28.5 billion in 2022 to USD 56.60 billion by 2030, growing at a CAGR of 10.3% during the forecast period (2023-2030).<br><br>

Ritesh30
Download Presentation

Global Anticoagulants Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Anticoagulants Market Size, Share, Growth Analysis - Industry Forecast 2023-2030 Global Anticoagulants Market size was valued at USD 27.9 billion in 2021 and is poised to grow from USD 28.5 billion in 2022 to USD 56.60 billion by 2030, growing at a CAGR of 10.3% during the forecast period (2023-2030). Global anticoagulants market has witnessed significant growth in recent years, driven by rising prevalence of chronic diseases and the adoption of unhealthy lifestyles that have contributed to the growing incidence of cardiovascular diseases. Consequently, there is a rising demand for anticoagulants in the market. According to the World Health Organization (WHO) and the Cureus Journal of Medical Science, cardiovascular diseases are a leading cause of death worldwide, with approximately 17.9 million deaths occurring annually, representing 35% of global deaths. Among these deaths, 85% are attributed to heart attacks and strokes. Ischemic heart disease (IHD) has emerged as a prominent contributor to global mortality. It affects around 126 million individuals approximately 1.72% of the world's population. Moreover, projections indicate that the prevalence of IHD is expected to surpass 1,845 per 100,000 individuals by 2030. Anticoagulants help prevent blood clotting, reducing the risk of heart attacks, strokes, and other cardiovascular complications. In addition to conventional anticoagulant therapies, novel oral anticoagulants (NOACs) have gained prominence. These newer drugs offer advantages such as improved safety profiles, simplified dosing regimens, and fewer drug interactions compared to traditional anticoagulants like warfarin. The growing adoption of NOACs by healthcare professionals and patients has further fueled the growth of the global anticoagulants market. worldwide, accounting for

  2. View More Info @:https://www.skyquestt.com/report/anticoagulants-market Top Player’s Company Profiles •Johnson & Johnson (US) •Boehringer Ingelheim International GmbH (Germany) •Sanofi S.A. (France) •Daiichi Sankyo Company, Limited (Japan) •Novartis International AG (Switzerland) •Eli Lilly and Company (US) •AstraZeneca PLC (UK) •Merck & Co., Inc. (US) •GlaxoSmithKline PLC (UK) •Abbott Laboratories (US) •Aspen Pharmacare Holdings Limited (South Africa) •Otsuka Holdings Co., Ltd. (Japan) •Mylan N.V. (US) •Takeda Pharmaceutical Company Limited (Japan) •Leo Pharma A/S (Denmark) AboutUs: SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally. Address: 1 Apache Way, Westford, Massachusetts 01886

  3. Phone: USA(+1)617-230-0741 Email: sales@skyquestt.com LinkedIn Facebook Twitter GLOBAL ANTICOAGULANTS SIZE GLOBAL ANTICOAGULANTS GROWTH GLOBAL ANTICOAGULANTS FORECAST

More Related